Dow Down 0.08% Nasdaq Down 0.35%

Exelixis, Inc. (EXEL)

-NasdaqGS
4.24 Down 0.01(0.24%) Feb 9, 4:00PM EST
Prev Close:4.25
Open:4.12
Bid:3.70 x 500
Ask:6.40 x 2000
1y Target Est:11.00
Beta:1.58423
Next Earnings Date:23-Feb-16EXEL Earnings announcement
Day's Range:4.00 - 4.46
52wk Range:2.10 - 6.81
Volume:6,830,555
Avg Vol (3m):4,469,950
Market Cap:963.40M
P/E (ttm):N/A
EPS (ttm):-0.91
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for EXEL

Comparison

Symbol% ChgMkt Cap
EXELDown 0.24%963.40M
GSKDown 0.33%95.20B
AZNDown 0.35%72.28B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):27.92
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.84
Quarterly EPS Est (Dec-15) :-0.22
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):0.21

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Exelixis, Inc., a biopharmaceutical company, develops and sells small molecule therapies for the treatment of cancer in the United States. The company offers COMETRIQ, an inhibitor of multiple receptor tyrosine kinases for the treatment of patient... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback